Vaccine Trial Design Overhaul For HIV, Malaria, Tuberculosis Is FDA/WHO Project Goal
14:34 EDT 11 Jun 2012 | Elsevier Business Intelligence
FDA grant will launch a collaborative agreement between the agency and the World Health Organization to create adaptive trial designs and explore new ways of tracking adverse event data.
Original Article: Vaccine Trial Design Overhaul For HIV, Malaria, Tuberculosis Is FDA/WHO Project Goal
More From BioPortfolio on "Vaccine Trial Design Overhaul For HIV, Malaria, Tuberculosis Is FDA/WHO Project Goal"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
